Sun Pharma Says US Regulator To Lift Ban On Mohali Drug Plant

Mumbai: Sun Pharmaceutical Industries Ltd, India's largest drug maker, said on Tuesday that US regulators plan to lift a ban on its Mohali plant in Punjab, allowing the company to restart supplies from there after four years. Sun gained the plant along with its acquisition of Ranbaxy Laboratories in 2015 and has been attempting to fix quality control problems there that the US Food and Drug Administration (FDA) identified in 2013. ...